You wake up in the morning and find food wrappers in the kitchen, a call record on your phone, or a family member telling you that you were walking around at night. You have no memory of it.
If this happened after taking a sleeping pill, it should not be dismissed as ordinary sleepiness. Clinically, this may be a complex sleep behavior, especially when certain Z-drugs are involved.
What does sleepwalking after a sleeping pill mean?
People often use the word sleepwalking for any nighttime behavior they do not remember. Medication-related complex sleep behaviors can be broader than walking.
Some people eat during the night. Some make phone calls, prepare food, leave the house, or do other activities while not fully awake. Rare but serious cases have involved driving, injuries, and death. In 2019, the U.S. Food and Drug Administration required boxed warnings for eszopiclone, zaleplon, and zolpidem because complex sleep behaviors after these medicines can lead to serious injuries or death[1].
This does not mean everyone who takes a Z-drug will sleepwalk. It means that if it has happened once, it deserves careful medical review.
What are complex sleep behaviors?
Complex sleep behaviors are activities performed while a person is not fully awake, often with little or no memory afterward. The behavior may look purposeful, which can make it confusing for family members.
[Table 1] Residual sedation, sleepwalking, and complex sleep behaviors
| Situation | What it may look like | Memory afterward | Why it matters |
|---|---|---|---|
| Residual sedation | Drowsy, slow, foggy | Usually remembered | May reflect lingering drug effect |
| Sleepwalking | Walking while asleep | Often absent | Needs assessment if repeated |
| Complex activity | Eating, calling, cooking | Often absent | May be a complex sleep behavior |
| Dangerous behavior | Driving, leaving home, using fire or knives | Often absent | Requires urgent safety review |
Patients may not report the problem because they do not remember it. Family observations are often the first clue: missing food, a messy kitchen, phone records, or seeing the person standing in the living room at night.
Which sleeping pills need special attention?
The FDA warning specifically names three Z-drugs: zolpidem, zaleplon, and eszopiclone[1]. These medicines are prescribed for insomnia, but in a small number of people they may be associated with complex sleep behaviors.
[Table 2] Z-drugs named in the FDA boxed warning
| Generic name | Common brand examples | FDA concern | Clinical note |
|---|---|---|---|
| zolpidem | Ambien, Stilnox | Complex sleep behaviors and serious injury risk | Strongest evidence among medication-induced sleepwalking reports |
| zaleplon | Sonata | Complex sleep behaviors and updated contraindication | Avoid re-use after a previous episode |
| eszopiclone | Lunesta | Complex sleep behaviors and serious injury risk | Next-day impairment and safety risks also matter |
The FDA states that healthcare professionals should not prescribe eszopiclone, zaleplon, or zolpidem to patients who have previously experienced complex sleep behaviors after taking any of these medicines[1].
That point is important. This is not simply a matter of trying a smaller dose next time. A previous episode changes the risk conversation.
It is not only an overdose problem
Many people assume these events happen only when someone takes too much medication, drinks alcohol, or mixes sedatives. Those factors can increase risk, but they are not the whole story.
Harbourt and colleagues analyzed postmarketing safety reports and published cases involving eszopiclone, zaleplon, and zolpidem. Their review found serious injuries from complex sleep behaviors, including cases that occurred at approved doses and cases without alcohol or other central nervous system depressants[3].
So the practical clinical question is not only, "Did the person take too much?" The more useful questions are: Did the behavior happen? Was it dangerous? Did it occur after taking the medication?
[Table 3] Common assumptions and better interpretations
| Common assumption | Better interpretation | Why it matters | Next step |
|---|---|---|---|
| It only happens after overdose | Approved doses have also been involved | Dose alone does not rule out risk | Contact the prescriber |
| No alcohol means no risk | Cases without alcohol have occurred | Alcohol is not the only factor | Review the medication reaction |
| It was just sleepwalking | Injury or dangerous behavior can occur | Safety planning is needed | Reduce environmental risk |
| No memory means it was not serious | Amnesia can be part of the warning sign | The patient may underestimate it | Family documentation helps |
What other medicines may be related to sleepwalking?
A systematic review by Stallman and colleagues identified 29 medications that had been reported in association with sleepwalking. The strongest evidence was for zolpidem and sodium oxybate[2].
Case reports have also involved some antidepressants, antipsychotics, and beta-blockers. This requires careful interpretation. A case report suggests possible association; it does not mean every medication in that class causes sleepwalking.
The most useful step is to build a clear timeline.
[Table 4] What to record before seeing the doctor
| What to record | Example | Why it helps | Note |
|---|---|---|---|
| Date and time | Around 2 a.m. | Compares behavior with medication timing | Family observations are useful |
| Medication details | Name, dose, time taken | Helps assess causality | Include supplements and non-prescription drugs |
| Alcohol or sedatives | Alcohol, pain medicine, other sleeping pills | Assesses interaction risk | Be direct with the clinician |
| Behavior | Eating, cooking, leaving home | Estimates danger level | Specific details matter |
| Memory afterward | None or partial memory | Supports complex sleep behavior assessment | Ask family to describe it |
Can someone take the same sleeping pill again after one episode?
If complex sleep behavior occurred after eszopiclone, zaleplon, or zolpidem, the FDA warning treats this as a contraindication for future use of these medicines[1].
The least safe response is to experiment alone by taking half a tablet, taking it less often, or assuming it will be fine next time. The concern is not just next-day drowsiness. It is unpredictable behavior while not fully awake.
Bring the details to the prescribing doctor: what happened, when the pill was taken, whether alcohol or other sedatives were used, and what the family observed. The doctor can decide whether to stop the medicine, switch treatment, or reassess the insomnia plan.
What should family members do during an episode?
If a family member sees unusual nighttime behavior, safety comes first. Avoid arguing, shaming, or shaking the person aggressively. Guide them gently away from danger and back toward bed if possible. Remove access to knives, fire, car keys, balconies, and other hazards.
[Table 5] Practical safety steps for family members
| Situation | What to do | What to avoid | Seek urgent care if |
|---|---|---|---|
| Walking at night | Calmly guide back to bed | Yelling or pulling forcefully | Fall, injury, persistent confusion |
| Night eating | Remove knives and unsafe food access | Treating it as simple snacking | Choking, allergy, ingestion risk |
| Using fire or gas | Secure the environment immediately | Waiting until morning | Burn or fire risk |
| Trying to leave or drive | Remove keys, stay nearby | Letting the person go alone | Injury, missing person, unsafe driving |
If there has been injury, driving, leaving home, aggression, heavy alcohol use, or mixing with other sedatives, the threshold for urgent medical help should be lower.
Insomnia treatment is broader than sleeping pills
Sleeping pills can have a role for some patients, but they are not the only insomnia treatment. In a 2024 review in the New England Journal of Medicine, Morin and Buysse noted that insomnia often occurs with other medical, psychiatric, and sleep disorders, and that cognitive behavioral therapy for insomnia, CBT-I, is an important first-line treatment[4].
After a complex sleep behavior, the treatment plan may need to change. The clinician may reassess anxiety, depression, sleep apnea, pain, alcohol use, caffeine, circadian rhythm, and medication interactions.
[Table 6] Alternative or supportive insomnia treatment directions
| Treatment direction | What it may include | When it fits | Comment |
|---|---|---|---|
| CBT-I | Sleep restriction, stimulus control, cognitive work | Chronic insomnia | Requires practice, not just advice |
| Medication adjustment | Stop, switch, reduce interaction risk | After complex sleep behavior | Should be clinician-guided |
| Comorbidity assessment | Anxiety, depression, sleep apnea, pain | Recurrent or resistant insomnia | Looks for drivers of insomnia |
| Rhythm and lifestyle work | Light, schedule, caffeine and alcohol review | Irregular sleep timing | Often combined with other treatment |
Frequently Asked Questions
Q1: Is sleepwalking a common side effect of zolpidem?
It is not expected in most users, but zolpidem has some of the strongest evidence among medications associated with sleepwalking[2]. If nighttime activity occurs and the person does not remember it, medical review is important.
Q2: Does this happen only when someone takes too much?
No. FDA safety reviews included serious cases that occurred at approved doses and cases without alcohol[3]. A normal dose does not rule out the possibility.
Q3: If it was only nighttime eating, do I still need to tell the doctor?
Yes. Night eating without memory may still be a complex sleep behavior. The point is not only whether harm occurred this time, but what could happen next time.
Q4: Can I stop the sleeping pill by myself?
Contact the prescribing doctor promptly, especially if complex sleep behavior occurred. The decision to stop, switch, or taper should consider the medication, insomnia severity, other medical conditions, and safety risks.
Q5: Are all Z-drugs dangerous?
No. Z-drugs may help some patients and most users do not experience complex sleep behaviors. The key message is narrower: if complex sleep behavior has occurred, it must be taken seriously.
Q6: Does alcohol increase the risk?
Alcohol and sedative-hypnotic medicines should not be mixed without medical guidance. Even though some reported cases occurred without alcohol, that does not make alcohol combination safe.
Further reading:
- When Should You Take Melatonin? Timing, Dose, and Safety
- Took a Sleeping Pill and Raided the Fridge? Zolpidem Complex Sleep Behaviours Explained
- Insomnia overview
- K6 psychological distress self-assessment
Dr. Tam's clinical note
If you have taken a sleeping pill and later learned that you walked, ate, cooked, called someone, or left the room with no memory, this deserves a proper medication review.
In clinic, I would first clarify three things: whether the behavior followed the medication, whether there was danger, and whether the medicine was one of the Z-drugs named in the FDA warning. From there, the discussion should move toward safer insomnia care, not self-experimentation.
The goal is not to make people fear every insomnia treatment. The goal is to recognize a serious warning sign early and choose a treatment path that is safer, trackable, and sustainable.
Want to book an appointment with Dr. Tam?
Psychiatrist at Ten-Chan & Ten-Hsiang General Hospital, Zhongli. Consultations in English, Mandarin and Cantonese.
Book AppointmentReferences
- U.S. Food and Drug Administration. Certain Prescription Insomnia Medicines: New Boxed Warning - Due to Risk of Serious Injuries Caused by Sleepwalking, Sleep Driving and Engaging in Other Activities While Not Fully Awake. 2019. FDA
- Stallman HM, Kohler M, White J. Medication induced sleepwalking: A systematic review. Sleep Med Rev. 2018;37:105-113. doi:10.1016/j.smrv.2017.01.005. DOI PubMed
- Harbourt K, Nevo ON, Zhang R, Chan V, Croteau D. Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. Pharmacoepidemiol Drug Saf. 2020;29(6):684-691. doi:10.1002/pds.5004. DOI PubMed
- Morin CM, Buysse DJ. Management of Insomnia. N Engl J Med. 2024;391(3):247-258. doi:10.1056/NEJMcp2305655. DOI PubMed